Literature DB >> 35122035

Circulating tumor DNA and liquid biopsy in oncology.

David W Cescon1, Scott V Bratman2, Steven M Chan1, Lillian L Siu3.   

Abstract

Techniques for analyzing circulating tumor DNA (ctDNA) to detect, characterize and monitor cancer have matured rapidly. An increasing body of clinical evidence is demonstrating the capabilities of this technology as a diagnostic test. The full potential of ctDNA liquid biopsy in the diagnosis, characterization and management of solid and hematological malignancies will be uncovered through interventional clinical trials evaluating clinical utility. In this Review, we discuss the current landscape of ctDNA liquid-biopsy applications across the cancer continuum and highlight opportunities for clinical investigation.
© 2020. Springer Nature America, Inc.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 35122035     DOI： 10.1038/s43018-020-0043-5

Source DB:  PubMed          Journal:  Nat Cancer        ISSN： 2662-1347


  97 in total

1.  Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

Authors:  Alain R Thierry; Florent Mouliere; Safia El Messaoudi; Caroline Mollevi; Evelyne Lopez-Crapez; Fanny Rolet; Brigitte Gillet; Celine Gongora; Pierre Dechelotte; Bruno Robert; Maguy Del Rio; Pierre-Jean Lamy; Frederic Bibeau; Michelle Nouaille; Virginie Loriot; Anne-Sophie Jarrousse; Franck Molina; Muriel Mathonnet; Denis Pezet; Marc Ychou
Journal:  Nat Med       Date:  2014-03-23       Impact factor: 53.440

Review 2.  Biopsies: next-generation biospecimens for tailoring therapy.

Authors:  Mark Basik; Adriana Aguilar-Mahecha; Caroline Rousseau; Zuanel Diaz; Sabine Tejpar; Alan Spatz; Celia M T Greenwood; Gerald Batist
Journal:  Nat Rev Clin Oncol       Date:  2013-06-25       Impact factor: 66.675

3.  Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer.

Authors:  Valsamo Anagnostou; Kellie N Smith; Patrick M Forde; Noushin Niknafs; Rohit Bhattacharya; James White; Theresa Zhang; Vilmos Adleff; Jillian Phallen; Neha Wali; Carolyn Hruban; Violeta B Guthrie; Kristen Rodgers; Jarushka Naidoo; Hyunseok Kang; William Sharfman; Christos Georgiades; Franco Verde; Peter Illei; Qing Kay Li; Edward Gabrielson; Malcolm V Brock; Cynthia A Zahnow; Stephen B Baylin; Robert B Scharpf; Julie R Brahmer; Rachel Karchin; Drew M Pardoll; Victor E Velculescu
Journal:  Cancer Discov       Date:  2016-12-28       Impact factor: 39.397

Review 4.  Liquid biopsies come of age: towards implementation of circulating tumour DNA.

Authors:  Jonathan C M Wan; Charles Massie; Javier Garcia-Corbacho; Florent Mouliere; James D Brenton; Carlos Caldas; Simon Pacey; Richard Baird; Nitzan Rosenfeld
Journal:  Nat Rev Cancer       Date:  2017-02-24       Impact factor: 60.716

5.  Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors:  Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

6.  Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.

Authors:  Tony S Mok; Yi-Long Wu; Sumitra Thongprasert; Chih-Hsin Yang; Da-Tong Chu; Nagahiro Saijo; Patrapim Sunpaweravong; Baohui Han; Benjamin Margono; Yukito Ichinose; Yutaka Nishiwaki; Yuichiro Ohe; Jin-Ji Yang; Busyamas Chewaskulyong; Haiyi Jiang; Emma L Duffield; Claire L Watkins; Alison A Armour; Masahiro Fukuoka
Journal:  N Engl J Med       Date:  2009-08-19       Impact factor: 91.245

7.  K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Authors:  Christos S Karapetis; Shirin Khambata-Ford; Derek J Jonker; Chris J O'Callaghan; Dongsheng Tu; Niall C Tebbutt; R John Simes; Haji Chalchal; Jeremy D Shapiro; Sonia Robitaille; Timothy J Price; Lois Shepherd; Heather-Jane Au; Christiane Langer; Malcolm J Moore; John R Zalcberg
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

8.  The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.

Authors:  Oliver A Zill; Kimberly C Banks; Stephen R Fairclough; Stefanie A Mortimer; James V Vowles; Reza Mokhtari; David R Gandara; Philip C Mack; Justin I Odegaard; Rebecca J Nagy; Arthur M Baca; Helmy Eltoukhy; Darya I Chudova; Richard B Lanman; AmirAli Talasaz
Journal:  Clin Cancer Res       Date:  2018-05-18       Impact factor: 12.531

9.  Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies.

Authors:  Justin I Odegaard; John J Vincent; Stefanie Mortimer; James V Vowles; Bryan C Ulrich; Kimberly C Banks; Stephen R Fairclough; Oliver A Zill; Marcin Sikora; Reza Mokhtari; Diana Abdueva; Rebecca J Nagy; Christine E Lee; Lesli A Kiedrowski; Cloud P Paweletz; Helmy Eltoukhy; Richard B Lanman; Darya I Chudova; AmirAli Talasaz
Journal:  Clin Cancer Res       Date:  2018-04-24       Impact factor: 12.531

Review 10.  Predictive biomarkers: a paradigm shift towards personalized cancer medicine.

Authors:  Nicholas B La Thangue; David J Kerr
Journal:  Nat Rev Clin Oncol       Date:  2011-08-23       Impact factor: 66.675
View more
  49 in total

1.  Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer.

Authors:  Ying Fan; Rui Sun; Zhizhong Wang; Yuying Zhang; Xiao Xiao; Yizhe Liu; Beibei Xin; Hui Xiong; Daru Lu; Jie Ma
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-18       Impact factor: 4.553

Review 2.  Tumour immunotherapy: lessons from predator-prey theory.

Authors:  Phineas T Hamilton; Bradley R Anholt; Brad H Nelson
Journal:  Nat Rev Immunol       Date:  2022-05-05       Impact factor: 53.106

Review 3.  Computational analysis of cancer genome sequencing data.

Authors:  Isidro Cortés-Ciriano; Doga C Gulhan; Jake June-Koo Lee; Giorgio E M Melloni; Peter J Park
Journal:  Nat Rev Genet       Date:  2021-12-08       Impact factor: 53.242

4.  Using All Our Genomes: Blood-based Liquid Biopsies for the Early Detection of Cancer.

Authors:  Eddie Adams; Gregory D Sepich-Poore; Sandrine Miller-Montgomery; Rob Knight
Journal:  View (Beijing)       Date:  2022-01-31

5.  Imaging Biomarkers and Liquid Biopsy in Assessment of Cervical Cancer.

Authors:  Mansur A Ghani; Joy Liau; Ramez Eskander; Loren Mell; Tahir Yusufaly; Sebastian Obrzut
Journal:  J Comput Assist Tomogr       Date:  2022-08-16       Impact factor: 2.081

Review 6.  Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges.

Authors:  Imran Noorani; Paul S Mischel; Charles Swanton
Journal:  Nat Rev Clin Oncol       Date:  2022-09-21       Impact factor: 65.011

7.  Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism.

Authors:  Maysa Abu-Khalaf; Chun Wang; Zhenchao Zhang; Rui Luo; Weelic Chong; Daniel P Silver; Frederick Fellin; Rebecca Jaslow; AnaMaria Lopez; Terrence Cescon; Wei Jiang; Ronald Myers; Qiang Wei; Bingshan Li; Massimo Cristofanilli; Hushan Yang
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

Review 8.  Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches.

Authors:  Giacomo Miserocchi; Chiara Spadazzi; Sebastiano Calpona; Francesco De Rosa; Alice Usai; Alessandro De Vita; Chiara Liverani; Claudia Cocchi; Silvia Vanni; Chiara Calabrese; Massimo Bassi; Giovanni De Luca; Giuseppe Meccariello; Toni Ibrahim; Marco Schiavone; Laura Mercatali
Journal:  J Pers Med       Date:  2022-05-24

9.  DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies.

Authors:  Emanuel Gonçalves; Maria Gonçalves-Reis; José B Pereira-Leal; Joana Cardoso
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

Review 10.  Kinase drug discovery 20 years after imatinib: progress and future directions.

Authors:  Philip Cohen; Darren Cross; Pasi A Jänne
Journal:  Nat Rev Drug Discov       Date:  2021-05-17       Impact factor: 112.288
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.